ResearcherArmy Medical UniversityActive in the last 2 years

Ying Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-7833-8836; OpenAlex author ID A5101475007. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

The 12-LOX/12-HETE/GPR31 metabolic pathway promotes tumor-associated macrophage M2 polarization mediated pancreatic cancer development. Co-author DOI 10.7717/peerj.19963 ↗
WITHDRAWN: Identifying diagnostic markers and constructing a prognostic model for pancreatic cancer based on microarray and bioinformatic analysis Co-author DOI 10.21203/rs.3.rs-4989505/v2 ↗
MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1. Co-author DOI 10.3892/ijo.2018.4445 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Liya Huang · 1 shared paper, 2025 · strength 0.33
- Paper The 12-LOX/12-HETE/GPR31 metabolic pathway promotes tumor-associated macrophage M2 polarization mediated pancreatic can… DOI 10.7717/peerj.19963 ↗
Jia Hui Wu · 1 shared paper, 2025 · strength 0.33
- Paper The 12-LOX/12-HETE/GPR31 metabolic pathway promotes tumor-associated macrophage M2 polarization mediated pancreatic can… DOI 10.7717/peerj.19963 ↗
Chunxiu Tan · 1 shared paper, 2025 · strength 0.33
- Paper The 12-LOX/12-HETE/GPR31 metabolic pathway promotes tumor-associated macrophage M2 polarization mediated pancreatic can… DOI 10.7717/peerj.19963 ↗
Yu You · 1 shared paper, 2024 · strength 0.24
- Paper WITHDRAWN: Identifying diagnostic markers and constructing a prognostic model for pancreatic cancer based on microarray… DOI 10.21203/rs.3.rs-4989505/v2 ↗
Liqun Zhang · 1 shared paper, 2024 · strength 0.24
- Paper WITHDRAWN: Identifying diagnostic markers and constructing a prognostic model for pancreatic cancer based on microarray… DOI 10.21203/rs.3.rs-4989505/v2 ↗
Chang-Miao Wang · 1 shared paper, 2018 · strength 0.12
- Paper MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration a… DOI 10.3892/ijo.2018.4445 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.